Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months

BACKGROUND. Neonatal candidiasis is associated with substantial morbidity and mortality rates. Neurodevelopmental follow-up data for a large multicenter cohort have not been reported. METHODS. Data were collected prospectively for neonates born at <1000 g at National Institute of Child Health and Human Development-sponsored Neonatal Research Network sites between September 1, 1998, and December 31, 2001. Uniform follow-up evaluations, including assessments of mental and motor development with the Bayley Scales of Infant Development II, were completed for all survivors at corrected ages of 18 to 22 months. We evaluated risk factors for the development of neonatal candidiasis, responses to antifungal therapy, and the association between candidiasis and subsequent morbidity and death. RESULTS. The cohort consisted of 4579 infants; 320 of 4579 (7%) developed candidiasis; 307 of 320 had Candida isolated from blood, 27 of 320 had Candida isolated from cerebrospinal fluid, and 13 (48%) of 27 of those with meningitis had negative blood cultures. In multivariate analysis of risk factors on day of life 3, birth weight, cephalosporins, gender, and lack of enteral feeding were associated with development of candidiasis. After diagnosis, most neonates had multiple positive cultures despite antifungal therapy, and 10% of neonates had candidemia for ≥14 days. Death or neurodevelopmental impairment (NDI) was observed for 73% of extremely low birth weight infants who developed candidiasis. Death and NDI rates were greater for infants who had delayed removal or replacement of central catheters (>1 day after initiation of antifungal therapy), compared with infants whose catheters were removed or replaced promptly. CONCLUSIONS. Blood cultures were negative for approximately one half of the infants with Candida meningitis. Persistent candidiasis was common. Delayed catheter removal was associated with increased death and NDI rates.

[1]  J D Horbar,et al.  Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. , 1991, Pediatrics.

[2]  L. Saiman,et al.  Risk factors for candidemia in Neonatal Intensive Care Unit patients , 2000, The Pediatric infectious disease journal.

[3]  N. Bayley.  Bayley Scales of Infant Development , 1999 .

[4]  W. Poole,et al.  To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. , 2004, Pediatrics.

[5]  T. Hulsey,et al.  Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. , 2001, Pediatrics.

[6]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[7]  D. Kaufman,et al.  Fluconazole prophylaxis against fungal colonization and infection in preterm infants. , 2001, The New England journal of medicine.

[8]  R. Auten,et al.  When to Suspect Fungal Infection in Neonates: A Clinical Comparison of Candida albicans and Candida parapsilosis Fungemia With Coagulase-Negative Staphylococcal Bacteremia , 2000, Pediatrics.

[9]  D. Noyola,et al.  Candidal meningitis in neonates: a 10-year review. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. Fairchild,et al.  Detection of Fungemia by Polymerase Chain Reaction in Critically Ill Neonates and Children , 2003, Journal of Perinatology.

[11]  L. Papile,et al.  Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. , 1978, The Journal of pediatrics.

[12]  L. Papile,et al.  INCIDENCE AND EVOLUTION OF SUBPENDYMAL AND INTRAVENTRICULAR HEMORRHAGE: A STUDY OF INFANTS WITH BIRTH WEIGHTS LESS THAN 1,500 GRAMS , 1978 .

[13]  E. Estey,et al.  β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome , 2004 .

[14]  ohn,et al.  COMPARISON OF CASPOFUNGIN AND AMPHOTERICIN B FOR INVASIVE CANDIDIASIS , 2002 .

[15]  T. Walsh,et al.  Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. , 2003, Pediatrics.

[16]  E. Buescher,et al.  Should Central Venous Catheters Be Removed as Soon as Candidemia Is Detected in Neonates? , 2000, Pediatrics.

[17]  S. Richardson,et al.  Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome , 2000, The Pediatric infectious disease journal.

[18]  C R Bauer,et al.  Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. , 2001, Pediatrics.

[19]  M. Smrkovsky,et al.  Bayley Scales of Infant Development - II - Nederlandse versie (BSID-II-NL) , 2003 .